BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
74.95
+4.22 (5.97%)
At close: Oct 30, 2026, 4:00 PM EDT
75.00
+0.05 (0.07%)
After-hours: Oct 30, 2026, 7:55 PM EDT
BridgeBio Pharma Employees
As of June 30, 2026, BridgeBio Pharma had 1,003 total employees, including 999 full-time and 4 part-time employees. The number of employees increased by 164 or 19.55% since the number was reported on December 31, 2025. That makes BridgeBio Pharma the 14,846th largest employer in the world and 2,169th in the United States.
Employees
1,003
Change
164
Growth
19.55%
Revenue / Employee
$942,712
Profits / Employee
-$590,354
Market Cap
14.60B
Employees Chart
| Date | Employees | Change | Growth | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1,003 | 164 | 19.55% | 999 | 4 |
| Dec 31, 2025 | 839 | 109 | 14.93% | 834 | 5 |
| Dec 31, 2024 | 730 | 174 | 31.29% | 725 | 5 |
| Dec 31, 2023 | 556 | 160 | 40.40% | 550 | 6 |
| Dec 31, 2022 | 396 | -182 | -31.49% | 392 | 4 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,000 |
| Jazz Pharmaceuticals | 2,890 |
| Caris Life Sciences | 1,846 |
| Ascendis Pharma | 1,189 |
| Exelixis | 1,077 |
| Twist Bioscience | 979 |
| Madrigal Pharmaceuticals | 915 |
BBIO News
- 1 day ago - BridgeBio Pharma price target raised to $88 from $87 at Morgan Stanley - TheFly
- 1 day ago - BridgeBio Pharma price target lowered to $100 from $110 at TD Cowen - TheFly
- 2 days ago - BridgeBio Pharma Earnings Call Transcript: Q3 2026 - Transcripts
- 2 days ago - BridgeBio Pharma Earnings release: Q3 2026 - Filings
- 2 days ago - BridgeBio Pharma Quarterly report: Q3 2026 - Filings
- 2 days ago - BridgeBio Pharma reports Q3 EPS (42c), consensus (56c) - TheFly
- 2 days ago - BridgeBio Reports Third Quarter 2026 Financial Results and Corporate Updates - GlobeNewsWire
- 3 days ago - BridgeBio Pharma Slides: Corporate presentation - Filings